News Image

DBV Confirms Alignment with U.S. FDA on Accelerated Approval Pathway for the Viaskin® Peanut Patch in Toddlers 1 – 3 Years-Old

Provided By GlobeNewswire

Last update: Dec 11, 2024

Châtillon, France, December 11th, 2024

DBV Confirms Alignment with U.S. FDA on Accelerated Approval Pathway for the Viaskin® Peanut Patch in Toddlers 1 – 3 Years-Old

Read more at globenewswire.com

DBV TECHNOLOGIES SA-SPON ADR

NASDAQ:DBVT (2/21/2025, 8:12:30 PM)

After market: 4.4 +0.01 (+0.11%)

4.395

+0.13 (+3.17%)



Find more stocks in the Stock Screener

Follow ChartMill for more